ENXTPA:IPNPharmaceuticals
Ipsen (ENXTPA:IPN): Rethinking Valuation After a Year of Steady Share Price Gains
Ipsen (ENXTPA:IPN) has been quietly grinding higher over the past year, and that steady climb is starting to draw more attention from long term investors watching European healthcare names.
See our latest analysis for Ipsen.
The stock has cooled a little in recent weeks, with a softer 1 month share price return, but its 90 day share price gain and double digit 1 year total shareholder return show momentum is still broadly constructive.
If Ipsen has you rethinking your healthcare exposure,...